全文获取类型
收费全文 | 1719105篇 |
免费 | 128888篇 |
国内免费 | 5428篇 |
专业分类
耳鼻咽喉 | 21980篇 |
儿科学 | 55919篇 |
妇产科学 | 46476篇 |
基础医学 | 244458篇 |
口腔科学 | 49153篇 |
临床医学 | 154878篇 |
内科学 | 337682篇 |
皮肤病学 | 38857篇 |
神经病学 | 132710篇 |
特种医学 | 64936篇 |
外国民族医学 | 266篇 |
外科学 | 260109篇 |
综合类 | 42871篇 |
现状与发展 | 9篇 |
一般理论 | 547篇 |
预防医学 | 126050篇 |
眼科学 | 40865篇 |
药学 | 126246篇 |
19篇 | |
中国医学 | 5752篇 |
肿瘤学 | 103638篇 |
出版年
2021年 | 14011篇 |
2019年 | 14344篇 |
2018年 | 20871篇 |
2017年 | 16020篇 |
2016年 | 17425篇 |
2015年 | 20184篇 |
2014年 | 27623篇 |
2013年 | 39195篇 |
2012年 | 54748篇 |
2011年 | 57538篇 |
2010年 | 34143篇 |
2009年 | 31802篇 |
2008年 | 53018篇 |
2007年 | 56341篇 |
2006年 | 56804篇 |
2005年 | 53989篇 |
2004年 | 51878篇 |
2003年 | 49331篇 |
2002年 | 47375篇 |
2001年 | 92311篇 |
2000年 | 94078篇 |
1999年 | 77410篇 |
1998年 | 20016篇 |
1997年 | 17592篇 |
1996年 | 17659篇 |
1995年 | 17000篇 |
1994年 | 15508篇 |
1993年 | 14219篇 |
1992年 | 57546篇 |
1991年 | 55406篇 |
1990年 | 53085篇 |
1989年 | 50823篇 |
1988年 | 46201篇 |
1987年 | 45006篇 |
1986年 | 42278篇 |
1985年 | 40035篇 |
1984年 | 29392篇 |
1983年 | 24923篇 |
1982年 | 13916篇 |
1979年 | 25540篇 |
1978年 | 17585篇 |
1977年 | 14915篇 |
1976年 | 13879篇 |
1975年 | 14564篇 |
1974年 | 17639篇 |
1973年 | 16952篇 |
1972年 | 15675篇 |
1971年 | 14457篇 |
1970年 | 13432篇 |
1969年 | 12517篇 |
排序方式: 共有10000条查询结果,搜索用时 29 毫秒
11.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
12.
Lei Yang You-Ling Shi Yan Ma Wei-Wei Ren Guang-Ming Pang Jiao Liu 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2022,130(1):43-52
Krüppel-like factor 16 (KLF16), a member of the Krüppel-like factor (KLF) family, has been extensively investigated in multiple cancer types. However, the role of KLF16 in oral squamous cell carcinoma (OSCC) remains unknown. Thus, we conducted this study to investigate its related mechanism. KLF16 expression in OSCC cell lines was quantified by western blotting. Then, OECM1 and OC3 cells were divided into Blank, siCtrl, siKLF16#1 and siKLF16#2 groups. Subsequently, cell proliferation was detected using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assays, cell migration and invasion were detected with wound healing and Transwell assays, and cell cycle distribution and cell apoptosis were detected via flow cytometry. KLF16, p21, CDK4, Cyclin D1 and p-Rb expression was detected by western blotting. Finally, xenograft models were established in nude mice to observe the in vivo effects of KLF16 on OSCC. KLF16 protein expression was upregulated in OSCC cells. Compared to the cells in the Blank group, the OECM1 and OC3 cells in the siKLF16#1 group and siKLF16#2 group exhibited a sharp decrease in proliferation but a remarkable increase in apoptosis. Moreover, the proportion of cells in the G0/G1 phase notably increased and that in the S phase decreased, with evident decreases in cell invasion and migration. Moreover, KLF16, cyclin-dependent kinase 4 (CDK4), Cyclin D1 and p-Rb protein expression was upregulated, but p21 expression was downregulated. The mice in the siKLF16#1 and siKLF16#2 xenograft model groups exhibited slower tumour growth and smaller tumours with evident downregulation of Ki67 expression compared to the mice in the Blank group. KLF16 expression was upregulated in OSCC cells, and interfering with KLF16 led to cell cycle arrest, inhibited OSCC cell growth and promoted cell apoptosis. 相似文献
13.
14.
Clinical & Experimental Metastasis - 相似文献
15.
16.
17.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
18.
19.